Skip to main content
Top
Published in: Malaria Journal 1/2021

Open Access 01-12-2021 | Malaria | Research

High frequency of the Duffy-negative genotype and absence of Plasmodium vivax infections in Ghana

Authors: Charles A. Brown, Prince J. Pappoe-Ashong, Nancy Duah, Anita Ghansah, Harry Asmah, Edwin Afari, Kwadwo A. Koram

Published in: Malaria Journal | Issue 1/2021

Login to get access

Abstract

Background

Recent studies from different malaria-endemic regions including western Africa have now shown that Plasmodium vivax can infect red blood cells (RBCs) and cause clinical disease in Duffy-negative people, though the Duffy-negative phenotype was thought to confer complete refractoriness against blood invasion with P. vivax. The actual prevalence of P. vivax in local populations in Ghana is unknown and little information is available about the distribution of Duffy genotypes. The aim of this study was to assess the prevalence of P. vivax in both asymptomatic and symptomatic outpatients and the distribution of Duffy genotypes in Ghana.

Methods

DNA was extracted from dried blood spots (DBS) collected from 952 subjects (845 malaria patients and 107 asymptomatic persons) from nine locations in Ghana. Plasmodium species identification was carried out by nested polymerase chain reaction (PCR) amplification of the small-subunit (SSU) rRNA genes. For P. vivax detection, a second PCR of the central region of the Pvcsp gene was carried out. Duffy blood group genotyping was performed by allele-specific PCR to detect the presence of the FYES allele.

Results

No cases of P. vivax were detected in any of the samples by both PCR methods used. Majority of infections (542, 94.8%) in the malaria patient samples were due to P. falciparum with only 1 infection (0.0017%) due to Plasmodium malariae, and 2 infections (0.0034%) due to Plasmodium ovale. No case of mixed infection was identified. Of the samples tested for the FYES allele from all the sites, 90.5% (862/952) had the FYES allele. All positive samples were genotyped as FY*B-33/FY*B-33 (Duffy-negative homozygous) and therefore classified as Fy(a−b−).

Conclusions

No cases of P. vivax were detected by both PCRs and majority of the subjects tested carried the FYES allele. The lack of P. vivax infections observed can be attributed to the high frequency of the FYES allele that silences erythroid expression of the Duffy. These results provide insights on the host susceptibility for P. vivax infections that had not been investigated in Ghana before.
Literature
1.
go back to reference WHO. World malaria report 2019. Geneva: World Health Organization; 2019. WHO. World malaria report 2019. Geneva: World Health Organization; 2019.
2.
go back to reference Mendes C, Dias F, Figueiredo J, Mora VG, Cano J, de Sousa B, et al. Duffy negative antigen is no longer a barrier to Plasmodium vivax—molecular evidences from the African West Coast (Angola and Equatorial Guinea). PLoS Negl Trop Dis. 2011;5:e1192.PubMedPubMedCentralCrossRef Mendes C, Dias F, Figueiredo J, Mora VG, Cano J, de Sousa B, et al. Duffy negative antigen is no longer a barrier to Plasmodium vivax—molecular evidences from the African West Coast (Angola and Equatorial Guinea). PLoS Negl Trop Dis. 2011;5:e1192.PubMedPubMedCentralCrossRef
3.
go back to reference WHO. World malaria report, 2016. Geneva: World Health Organization; 2016. WHO. World malaria report, 2016. Geneva: World Health Organization; 2016.
4.
go back to reference Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009;9:555–66.PubMedCrossRef Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009;9:555–66.PubMedCrossRef
5.
6.
go back to reference Alexandre MA, Ferreira CO, Siqueira AM, Magalhaes BL, Mourao MP, Lacerda MV, et al. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis. 2010;16:1611–4.PubMedPubMedCentralCrossRef Alexandre MA, Ferreira CO, Siqueira AM, Magalhaes BL, Mourao MP, Lacerda MV, et al. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis. 2010;16:1611–4.PubMedPubMedCentralCrossRef
7.
go back to reference Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med. 1976;295:302–3044.PubMedCrossRef Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med. 1976;295:302–3044.PubMedCrossRef
8.
go back to reference Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK. Erythrocyte receptors for Plasmodium knowlesi malaria: Duffy blood group determinants. Science. 1975;189:561–3.PubMedCrossRef Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK. Erythrocyte receptors for Plasmodium knowlesi malaria: Duffy blood group determinants. Science. 1975;189:561–3.PubMedCrossRef
9.
go back to reference Parasol N, Reid M, Rios M, Castilho L, Harari I, Kosower NS. A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype. Blood. 1998;92:2237–43.PubMedCrossRef Parasol N, Reid M, Rios M, Castilho L, Harari I, Kosower NS. A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype. Blood. 1998;92:2237–43.PubMedCrossRef
10.
go back to reference Tournamille C, Colin Y, Cartron JP, Le Van KC. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet. 1995;10:224–8.PubMedCrossRef Tournamille C, Colin Y, Cartron JP, Le Van KC. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet. 1995;10:224–8.PubMedCrossRef
11.
go back to reference Miller LH, Aikawa M, Johnson JG, Shiroishi T. Interaction between cytochalasin B-treated malarial parasites and erythrocytes. Attachment and junction formation. J Exp Med. 1979;149:172–84.PubMedCrossRef Miller LH, Aikawa M, Johnson JG, Shiroishi T. Interaction between cytochalasin B-treated malarial parasites and erythrocytes. Attachment and junction formation. J Exp Med. 1979;149:172–84.PubMedCrossRef
12.
go back to reference Carvalho TA, Queiroz MG, Cardoso GL, Diniz IG, Silva AN, Pinto AY, et al. Plasmodium vivax infection in Anajas, State of Para: no differential resistance profile among Duffy-negative and Duffy-positive individuals. Malar J. 2012;11:430.PubMedPubMedCentralCrossRef Carvalho TA, Queiroz MG, Cardoso GL, Diniz IG, Silva AN, Pinto AY, et al. Plasmodium vivax infection in Anajas, State of Para: no differential resistance profile among Duffy-negative and Duffy-positive individuals. Malar J. 2012;11:430.PubMedPubMedCentralCrossRef
13.
go back to reference Lo E, Yewhalaw D, Zhong D, Zemene E, Degefa T, Tushune K, et al. Molecular epidemiology of Plasmodium vivax and Plasmodium falciparum malaria among Duffy-positive and Duffy-negative populations in Ethiopia. Malar J. 2015;14:84.PubMedPubMedCentralCrossRef Lo E, Yewhalaw D, Zhong D, Zemene E, Degefa T, Tushune K, et al. Molecular epidemiology of Plasmodium vivax and Plasmodium falciparum malaria among Duffy-positive and Duffy-negative populations in Ethiopia. Malar J. 2015;14:84.PubMedPubMedCentralCrossRef
14.
go back to reference Woldearegai TG, Kremsner PG, Kun JF, Mordmuller B. Plasmodium vivax malaria in Duffy-negative individuals from Ethiopia. Trans R Soc Trop Med Hyg. 2013;107:328–31.PubMedCrossRef Woldearegai TG, Kremsner PG, Kun JF, Mordmuller B. Plasmodium vivax malaria in Duffy-negative individuals from Ethiopia. Trans R Soc Trop Med Hyg. 2013;107:328–31.PubMedCrossRef
15.
go back to reference Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, et al. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA. 2010;107:5967–71.PubMedCrossRef Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, et al. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA. 2010;107:5967–71.PubMedCrossRef
16.
go back to reference Ryan JR, Stoute JA, Amon J, Dunton RF, Mtalib R, Koros J, et al. Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. Am J Trop Med Hyg. 2006;75:575–81.PubMedCrossRef Ryan JR, Stoute JA, Amon J, Dunton RF, Mtalib R, Koros J, et al. Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. Am J Trop Med Hyg. 2006;75:575–81.PubMedCrossRef
17.
go back to reference Wurtz N, Mint Lekweiry K, Bogreau H, Pradines B, Rogier C, Ould Mohamed Salem Boukhary A, et al. Vivax malaria in Mauritania includes infection of a Duffy-negative individual. Malar J. 2011;10:336.PubMedPubMedCentralCrossRef Wurtz N, Mint Lekweiry K, Bogreau H, Pradines B, Rogier C, Ould Mohamed Salem Boukhary A, et al. Vivax malaria in Mauritania includes infection of a Duffy-negative individual. Malar J. 2011;10:336.PubMedPubMedCentralCrossRef
18.
go back to reference Fru-Cho J, Bumah VV, Safeukui I, Nkuo-Akenji T, Titanji VP, Haldar K. Molecular typing reveals substantial Plasmodium vivax infection in asymptomatic adults in a rural area of Cameroon. Malar J. 2014;13:170.PubMedPubMedCentralCrossRef Fru-Cho J, Bumah VV, Safeukui I, Nkuo-Akenji T, Titanji VP, Haldar K. Molecular typing reveals substantial Plasmodium vivax infection in asymptomatic adults in a rural area of Cameroon. Malar J. 2014;13:170.PubMedPubMedCentralCrossRef
19.
go back to reference Ngassa Mbenda HG, Das A. Molecular evidence of Plasmodium vivax mono and mixed malaria parasite infections in Duffy-negative native Cameroonians. PLoS ONE. 2014;9:e103262.PubMedPubMedCentralCrossRef Ngassa Mbenda HG, Das A. Molecular evidence of Plasmodium vivax mono and mixed malaria parasite infections in Duffy-negative native Cameroonians. PLoS ONE. 2014;9:e103262.PubMedPubMedCentralCrossRef
20.
go back to reference Bernabeu M, Gomez-Perez GP, Sissoko S, Niambele MB, Haibala AA, Sanz A, et al. Plasmodium vivax malaria in Mali: a study from three different regions. Malar J. 2012;11:405.PubMedPubMedCentralCrossRef Bernabeu M, Gomez-Perez GP, Sissoko S, Niambele MB, Haibala AA, Sanz A, et al. Plasmodium vivax malaria in Mali: a study from three different regions. Malar J. 2012;11:405.PubMedPubMedCentralCrossRef
21.
go back to reference Poirier P, Doderer-Lang C, Atchade PS, Lemoine JP, de l’Isle MC, Abou-Bacar A, et al. The hide and seek of Plasmodium vivax in West Africa: report from a large-scale study in Beninese asymptomatic subjects. Malar J. 2016;15:570.PubMedPubMedCentralCrossRef Poirier P, Doderer-Lang C, Atchade PS, Lemoine JP, de l’Isle MC, Abou-Bacar A, et al. The hide and seek of Plasmodium vivax in West Africa: report from a large-scale study in Beninese asymptomatic subjects. Malar J. 2016;15:570.PubMedPubMedCentralCrossRef
22.
23.
go back to reference Russo G, Faggioni G, Paganotti GM, Djeunang Dongho GB, Pomponi A, De Santis R, et al. Molecular evidence of Plasmodium vivax infection in Duffy negative symptomatic individuals from Dschang, West Cameroon. Malar J. 2017;16:74.PubMedPubMedCentralCrossRef Russo G, Faggioni G, Paganotti GM, Djeunang Dongho GB, Pomponi A, De Santis R, et al. Molecular evidence of Plasmodium vivax infection in Duffy negative symptomatic individuals from Dschang, West Cameroon. Malar J. 2017;16:74.PubMedPubMedCentralCrossRef
24.
go back to reference Mercereau-Puijalon O, Ménard D. Plasmodium vivax and the Duffy antigen: a paradigm revisited. Transfus Clin Biol. 2010;17:176–83.PubMedCrossRef Mercereau-Puijalon O, Ménard D. Plasmodium vivax and the Duffy antigen: a paradigm revisited. Transfus Clin Biol. 2010;17:176–83.PubMedCrossRef
25.
go back to reference Culleton RL, Mita T, Ndounga M, Unger H, Cravo PV, Paganotti GM, et al. Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar J. 2008;7:174.PubMedPubMedCentralCrossRef Culleton RL, Mita T, Ndounga M, Unger H, Cravo PV, Paganotti GM, et al. Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar J. 2008;7:174.PubMedPubMedCentralCrossRef
26.
go back to reference Abuaku B, Duah N, Quaye L, Quashie N, Koram K. Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana. Malar J. 2012;11:388.PubMedPubMedCentralCrossRef Abuaku B, Duah N, Quaye L, Quashie N, Koram K. Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana. Malar J. 2012;11:388.PubMedPubMedCentralCrossRef
27.
go back to reference Duah NO, Quashie NB, Abuaku BK, Sebeny PJ, Kronmann KC, Koram KA. Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana. Am J Trop Med Hyg. 2012;87:966–1003.CrossRef Duah NO, Quashie NB, Abuaku BK, Sebeny PJ, Kronmann KC, Koram KA. Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana. Am J Trop Med Hyg. 2012;87:966–1003.CrossRef
28.
go back to reference Duah NO, Wilson M, Ghansah A, Abuaku B, Edoh D, Quashie N, et al. Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria. J Trop Pediatr. 2007;53:27–31.PubMedCrossRef Duah NO, Wilson M, Ghansah A, Abuaku B, Edoh D, Quashie N, et al. Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria. J Trop Pediatr. 2007;53:27–31.PubMedCrossRef
30.
go back to reference Accra Metropolitan Assembly & C40 Cities. Accra Climate Action Plan: first five-year plan (2020–2025). Accra, 2020. Accra Metropolitan Assembly & C40 Cities. Accra Climate Action Plan: first five-year plan (2020–2025). Accra, 2020.
31.
go back to reference Asadzaheh N, Javanmard A, Nassiry MR. Comparison of rapid DNA extraction techniques for conventional PCR-RFLP analysis from mammalian whole blood cells. J Mol Genet. 2010;2:32–5.CrossRef Asadzaheh N, Javanmard A, Nassiry MR. Comparison of rapid DNA extraction techniques for conventional PCR-RFLP analysis from mammalian whole blood cells. J Mol Genet. 2010;2:32–5.CrossRef
32.
go back to reference Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61:315–20.PubMedCrossRef Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61:315–20.PubMedCrossRef
33.
go back to reference Alves RT, Póvoa MM, Goldman IF, Cavasini CE, Rossit AR, Machado RL. A new polymerase chain reaction/restriction fragment length polymorphism protocol for Plasmodium vivax circumsporozoite protein genotype (VK210, VK247, and P. vivax-like) determination. Diagn Microbiol Infect Dis. 2007;59:415–9.PubMedCrossRef Alves RT, Póvoa MM, Goldman IF, Cavasini CE, Rossit AR, Machado RL. A new polymerase chain reaction/restriction fragment length polymorphism protocol for Plasmodium vivax circumsporozoite protein genotype (VK210, VK247, and P. vivax-like) determination. Diagn Microbiol Infect Dis. 2007;59:415–9.PubMedCrossRef
34.
go back to reference Olsson ML, Hansson C, Avent ND, Akesson IE, Green CA, Daniels GL. A clinically applicable method for determining the three major alleles at the Duffy (FY) blood group locus using polymerase chain reaction with allele-specific primers. Transfusion. 1998;38:168–73.PubMedCrossRef Olsson ML, Hansson C, Avent ND, Akesson IE, Green CA, Daniels GL. A clinically applicable method for determining the three major alleles at the Duffy (FY) blood group locus using polymerase chain reaction with allele-specific primers. Transfusion. 1998;38:168–73.PubMedCrossRef
35.
go back to reference Crottet SL, Henny C, Meyer S, Still F, Stolz M, Gottschalk J, et al. Implementation of a mandatory donor RHD screening in Switzerland. Transfus Apher Sci. 2014;50:169–74.PubMedCrossRef Crottet SL, Henny C, Meyer S, Still F, Stolz M, Gottschalk J, et al. Implementation of a mandatory donor RHD screening in Switzerland. Transfus Apher Sci. 2014;50:169–74.PubMedCrossRef
36.
go back to reference Ba H, Duffy CW, Ahouidi AD, Deh YB, Diallo MY, Tandia A, et al. Widespread distribution of Plasmodium vivax malaria in Mauritania on the interface of the Maghreb and West Africa. Malar J. 2016;15:80.PubMedPubMedCentralCrossRef Ba H, Duffy CW, Ahouidi AD, Deh YB, Diallo MY, Tandia A, et al. Widespread distribution of Plasmodium vivax malaria in Mauritania on the interface of the Maghreb and West Africa. Malar J. 2016;15:80.PubMedPubMedCentralCrossRef
37.
go back to reference Rogier E, Moss DM, Chard AN, Trinies V, Doumbia S, Freeman MC, et al. Evaluation of immunoglobulin G Responses to Plasmodium falciparum and Plasmodium vivax in Malian school children using multiplex bead assay. Am J Trop Med Hyg. 2017;96:312–8.PubMedPubMedCentralCrossRef Rogier E, Moss DM, Chard AN, Trinies V, Doumbia S, Freeman MC, et al. Evaluation of immunoglobulin G Responses to Plasmodium falciparum and Plasmodium vivax in Malian school children using multiplex bead assay. Am J Trop Med Hyg. 2017;96:312–8.PubMedPubMedCentralCrossRef
38.
go back to reference Abdul-Aziz AR, Harris E, Munyakazi L. Risk factors in malaria mortality among children in Northern Ghana: a case study at the Tamale Teaching Hospital. Int J Bus Soc Res. 2012;2:35–45. Abdul-Aziz AR, Harris E, Munyakazi L. Risk factors in malaria mortality among children in Northern Ghana: a case study at the Tamale Teaching Hospital. Int J Bus Soc Res. 2012;2:35–45.
39.
40.
go back to reference Okell LC, Bousema T, Griffin JT, Ouédraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.PubMedPubMedCentralCrossRef Okell LC, Bousema T, Griffin JT, Ouédraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.PubMedPubMedCentralCrossRef
41.
go back to reference Heinemann M, Phillips RO, Vinnemeier CD, Rolling CC, Tannich E, Rolling T. High prevalence of asymptomatic malaria infections in adults, Ashanti Region, Ghana, 2018. Malar J. 2020;19:366.PubMedPubMedCentralCrossRef Heinemann M, Phillips RO, Vinnemeier CD, Rolling CC, Tannich E, Rolling T. High prevalence of asymptomatic malaria infections in adults, Ashanti Region, Ghana, 2018. Malar J. 2020;19:366.PubMedPubMedCentralCrossRef
42.
go back to reference Owusu ED, Buabeng V, Dadzie S, Brown CA, Grobusch MP, Mens P. Characteristics of asymptomatic Plasmodium spp. parasitaemia in Kwahu-Mpraeso, a malaria endemic mountainous district in Ghana, West Africa. Malar J. 2016;15:38.PubMedPubMedCentralCrossRef Owusu ED, Buabeng V, Dadzie S, Brown CA, Grobusch MP, Mens P. Characteristics of asymptomatic Plasmodium spp. parasitaemia in Kwahu-Mpraeso, a malaria endemic mountainous district in Ghana, West Africa. Malar J. 2016;15:38.PubMedPubMedCentralCrossRef
43.
go back to reference Lamptey H, Ofori MF, Kusi KA, Adu B, Owusu-Yeboa E, Kyei-Baafour E, et al. The prevalence of submicroscopic Plasmodium falciparum gametocyte carriage and multiplicity of infection in children, pregnant women and adults in a low malaria transmission area in Southern Ghana. Malar J. 2018;17:331.PubMedPubMedCentralCrossRef Lamptey H, Ofori MF, Kusi KA, Adu B, Owusu-Yeboa E, Kyei-Baafour E, et al. The prevalence of submicroscopic Plasmodium falciparum gametocyte carriage and multiplicity of infection in children, pregnant women and adults in a low malaria transmission area in Southern Ghana. Malar J. 2018;17:331.PubMedPubMedCentralCrossRef
44.
go back to reference Diallo N, Akweongo P, Maya E, Aikins M, Sarfo B. Burden of malaria in mobile populations in the Greater Accra region, Ghana: a cross-sectional study. Malar J. 2017;16:109.PubMedPubMedCentralCrossRef Diallo N, Akweongo P, Maya E, Aikins M, Sarfo B. Burden of malaria in mobile populations in the Greater Accra region, Ghana: a cross-sectional study. Malar J. 2017;16:109.PubMedPubMedCentralCrossRef
45.
go back to reference Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12:833–40.PubMedCrossRef Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12:833–40.PubMedCrossRef
46.
go back to reference Li Y, Wang G, Sun D, Meng F, Lin S, Hu X, et al. A case of Plasmodium ovale wallikeri infection in a Chinese worker returning from West Africa. Korean J Parasitol. 2013;51:557–62.PubMedPubMedCentralCrossRef Li Y, Wang G, Sun D, Meng F, Lin S, Hu X, et al. A case of Plasmodium ovale wallikeri infection in a Chinese worker returning from West Africa. Korean J Parasitol. 2013;51:557–62.PubMedPubMedCentralCrossRef
48.
49.
go back to reference Howes RE, Reiner RC Jr, Battle KE, Longbottom J, Mappin B, Ordanovich D, et al. Plasmodium vivax transmission in Africa. PLoS Negl Trop Dis. 2015;9:e0004222.PubMedPubMedCentralCrossRef Howes RE, Reiner RC Jr, Battle KE, Longbottom J, Mappin B, Ordanovich D, et al. Plasmodium vivax transmission in Africa. PLoS Negl Trop Dis. 2015;9:e0004222.PubMedPubMedCentralCrossRef
50.
go back to reference He X, Pan M, Zeng W, Zou C, Pi L, Qin Y, et al. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report. BMC Infect Dis. 2019;19:704.PubMedPubMedCentralCrossRef He X, Pan M, Zeng W, Zou C, Pi L, Qin Y, et al. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report. BMC Infect Dis. 2019;19:704.PubMedPubMedCentralCrossRef
51.
go back to reference Yan L, Fu Q, Jin L, Li L. Duffy blood group phenotypes and genotypes in Chinese. Transfusion. 2001;41:970.PubMedCrossRef Yan L, Fu Q, Jin L, Li L. Duffy blood group phenotypes and genotypes in Chinese. Transfusion. 2001;41:970.PubMedCrossRef
52.
go back to reference Ayorinde AF, Oyeyiga AM, Nosegbe NO, Folarin OA. A survey of malaria and some arboviral infections among suspected febrile patients visiting a health centre in Simawa, Ogun State, Nigeria. J Infect Public Health. 2016;9:52–9.PubMedCrossRef Ayorinde AF, Oyeyiga AM, Nosegbe NO, Folarin OA. A survey of malaria and some arboviral infections among suspected febrile patients visiting a health centre in Simawa, Ogun State, Nigeria. J Infect Public Health. 2016;9:52–9.PubMedCrossRef
53.
go back to reference Oboh MA, Badiane AS, Ntadom G, Ndiaye YD, Diongue K, Diallo MA, et al. Molecular identification of Plasmodium species responsible for malaria reveals Plasmodium vivax isolates in Duffy negative individuals from southwestern Nigeria. Malar J. 2018;17:439.PubMedPubMedCentralCrossRef Oboh MA, Badiane AS, Ntadom G, Ndiaye YD, Diongue K, Diallo MA, et al. Molecular identification of Plasmodium species responsible for malaria reveals Plasmodium vivax isolates in Duffy negative individuals from southwestern Nigeria. Malar J. 2018;17:439.PubMedPubMedCentralCrossRef
54.
go back to reference Ba H, Ahouidi AD, Duffy CW, Deh YB, Diedhiou C, Tandia A, et al. Evaluation of malaria rapid diagnostic test Optimal-IT(R) pLDH along the Plasmodium falciparum distribution limit in Mauritania. Bull Soc Pathol Exot. 2017;110:31–7 (in French).PubMedCrossRef Ba H, Ahouidi AD, Duffy CW, Deh YB, Diedhiou C, Tandia A, et al. Evaluation of malaria rapid diagnostic test Optimal-IT(R) pLDH along the Plasmodium falciparum distribution limit in Mauritania. Bull Soc Pathol Exot. 2017;110:31–7 (in French).PubMedCrossRef
55.
go back to reference Niangaly A, Karthigayan G, Amed O, Coulibaly D, Sa JM, Adams M, et al. Plasmodium vivax infections over 3 years in Duffy blood group negative Malians in Bandiagara, Mali. Am J Trop Med Hyg. 2017;97:744–52.PubMedPubMedCentralCrossRef Niangaly A, Karthigayan G, Amed O, Coulibaly D, Sa JM, Adams M, et al. Plasmodium vivax infections over 3 years in Duffy blood group negative Malians in Bandiagara, Mali. Am J Trop Med Hyg. 2017;97:744–52.PubMedPubMedCentralCrossRef
56.
go back to reference Twohig KA, Pfeffer DA, Baird JK, Price RN, Zimmerman PA, Hay SI, et al. Growing evidence of Plasmodium vivax across malaria-endemic Africa. PLoS Negl Trop Dis. 2019;13:e0007140.PubMedPubMedCentralCrossRef Twohig KA, Pfeffer DA, Baird JK, Price RN, Zimmerman PA, Hay SI, et al. Growing evidence of Plasmodium vivax across malaria-endemic Africa. PLoS Negl Trop Dis. 2019;13:e0007140.PubMedPubMedCentralCrossRef
57.
go back to reference Sundararaman SA, Liu W, Keele BF, Learn GH, Bittinger K, Mouacha F, et al. Plasmodium falciparum-like parasites infecting wild apes in southern Cameroon do not represent a recurrent source of human malaria. Proc Natl Acad Sci USA. 2013;110:7020–5.PubMedCrossRef Sundararaman SA, Liu W, Keele BF, Learn GH, Bittinger K, Mouacha F, et al. Plasmodium falciparum-like parasites infecting wild apes in southern Cameroon do not represent a recurrent source of human malaria. Proc Natl Acad Sci USA. 2013;110:7020–5.PubMedCrossRef
58.
go back to reference Livingstone FB. The Duffy blood groups, vivax malaria, and malaria selection in human populations: a review. Hum Biol. 1984;56:413–25.PubMed Livingstone FB. The Duffy blood groups, vivax malaria, and malaria selection in human populations: a review. Hum Biol. 1984;56:413–25.PubMed
59.
go back to reference Gunalan K, Lo E, Hostetler JB, Yewhalaw D, Mu J, Neafsey DE, et al. Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans. Proc Nat Acad Sci USA. 2016;113:6271–6.PubMedCrossRef Gunalan K, Lo E, Hostetler JB, Yewhalaw D, Mu J, Neafsey DE, et al. Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans. Proc Nat Acad Sci USA. 2016;113:6271–6.PubMedCrossRef
60.
61.
go back to reference Gruszczyk J, Kanjee U, Chan LJ, Menant S, Malleret B, Lim NTY, et al. Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax. Science. 2018;359:48–55.PubMedPubMedCentralCrossRef Gruszczyk J, Kanjee U, Chan LJ, Menant S, Malleret B, Lim NTY, et al. Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax. Science. 2018;359:48–55.PubMedPubMedCentralCrossRef
62.
go back to reference Malleret B, El Sahili A, Howland SW, Suwanarusk R, Ong ASM, Kosaisavee V, et al. CD98 is a Plasmodium vivax receptor for human reticulocytes. In: Proceedings of international conference on Plasmodium vivax, Campinas, Galoá; 2017. Malleret B, El Sahili A, Howland SW, Suwanarusk R, Ong ASM, Kosaisavee V, et al. CD98 is a Plasmodium vivax receptor for human reticulocytes. In: Proceedings of international conference on Plasmodium vivax, Campinas, Galoá; 2017.
Metadata
Title
High frequency of the Duffy-negative genotype and absence of Plasmodium vivax infections in Ghana
Authors
Charles A. Brown
Prince J. Pappoe-Ashong
Nancy Duah
Anita Ghansah
Harry Asmah
Edwin Afari
Kwadwo A. Koram
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2021
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-021-03618-0

Other articles of this Issue 1/2021

Malaria Journal 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.